Insider Transactions Reported by 11 Insiders of Salarius Pharmaceuticals, Inc.

Symbol
SLRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
Houston, TX

Insiders trading volume in the past year

Salarius Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Frederick Pierce II Chief Executive Office $65.3K Nov 12, 2025
Mark J. Rosenblum Exec VP Finance, CFO $16.1K +$16K +11348% Nov 20, 2025
Arnold C. Hanish Director $3.8K +$3.74K +6563% Nov 20, 2025
William K. McVicar Director Feb 20, 2024
Bruce J. McCreedy Jr. Director Feb 20, 2024
David J. Arthur Chief Executive Officer, Director Apr 11, 2024
Paul Lammers Director Feb 20, 2024
Barbara Louise Hibner Chief Scientific Officer Nov 12, 2025
Peter Klaus Marschel Chief Business Officer Nov 12, 2025
Jonathan I. Lieber Director Feb 20, 2024
Tess Burleson Director Feb 20, 2024

Recent Insider Transactions by Companies or Individuals for Salarius Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.